Financhill
Buy
54

XFOR Quote, Financials, Valuation and Earnings

Last price:
$4.12
Seasonality move :
-4.47%
Day range:
$4.01 - $4.27
52-week range:
$1.35 - $26.83
Dividend yield:
0%
P/E ratio:
0.70x
P/S ratio:
1.95x
P/B ratio:
5.85x
Volume:
853.4K
Avg. volume:
780.5K
1-year change:
-76.2%
Market cap:
$360.2M
Revenue:
$2.6M
EPS (TTM):
-$10.01

Earnings Data

Next earnings date for XFOR
Mar 24
2026
Most recent earnings per share
-$0.69
Beat by $0.15
(Nov 5/2025)
Consensus Estimate
-$0.84
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XFOR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 $1.7M -- -- -$0.34 --
11/05/2025 Q3 $1.9M $1.8M -$0.69 -$0.84 $0.15
08/14/2025 Q2 $1.6M $2M -$3.47 -$4.34 $0.86
05/01/2025 Q1 $7M $28.8M $0.04 -$3.75 $3.79
03/25/2025 Q4 $1.1M $1.4M -$5.89 -$4.73 -$1.16
11/13/2024 Q3 $1.7M $560K -$0.18 -$5.16 $4.98
08/08/2024 Q2 $15.3M $563K $0.45 $0.75 -$0.30
05/07/2024 Q1 -- -- -$0.26 -$4.35 $4.09
03/21/2024 Q4 -- -- -$0.10 -$4.55 $4.45
11/09/2023 Q3 -- -- -$0.01 -$4.29 $4.27
08/10/2023 Q2 -- -- -$0.33 -- --
05/04/2023 Q1 -- -- -$0.16 -- --
03/21/2023 Q4 -- -- -$0.29 -- --
11/03/2022 Q3 -- -- -$0.26 -- --
08/04/2022 Q2 -- -- -$0.60 -- --
05/12/2022 Q1 -- -- -$0.72 -- --
03/17/2022 Q4 -- -- -$1.24 -- --
11/04/2021 Q3 -- -- -$0.76 -- --
08/03/2021 Q2 -- -- -$0.74 -- --
05/06/2021 Q1 -- -- -$1.30 -- --
03/04/2021 Q4 -- -- -$0.91 -- --
11/05/2020 Q3 -- -- -$0.87 -- --
07/30/2020 Q2 -- -- -$0.76 -- --
05/07/2020 Q1 -- $3M -$0.56 -- --
03/12/2020 Q4 -- -- -$0.66 -- --
11/07/2019 Q3 -- -- -$1.22 -- --
08/07/2019 Q2 -- -- -$1.02 -- --
05/15/2019 Q1 -- -- -$6.67 -- --
03/11/2019 Q4 -- -- -$4,561.78 -- --
09/30/2018 Q3 -- -- -$611.64 -- --
06/30/2018 Q2 -- -- -$16,019.25 -- --
03/31/2018 Q1 -- -- -$19,118.15 -- --
12/31/2017 Q4 -- -- -$1,816.71 -- --
09/30/2017 Q3 -- -- -$24,411.91 -- --
06/30/2017 Q2 -- -- -$14.40 -- --
03/31/2017 Q1 -- -- -$13.58 -- --
12/31/2016 Q4 -- -- -$172.21 -- --
03/31/2016 Q1 -- -- -$8.83 -- --

X4 Pharmaceuticals, Inc. Earnings Questions

  • How Much did X4 Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    X4 Pharmaceuticals, Inc. reported $1.8M worth of top line sales in its most recent quarter.

  • Did X4 Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    X4 Pharmaceuticals, Inc. announced earnings per share of -$0.69 which represents a beat of analyst forecast a -$0.84 per share.

  • Is X4 Pharmaceuticals, Inc. Profitable?

    X4 Pharmaceuticals, Inc. reported $1.4M that represents $0.03 per share over the last quarter.

  • What is the Analyst Consensus for X4 Pharmaceuticals, Inc. EPS Next Year?

    X4 Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$5.59 per share to -$4.58 per share next year representing a decrease of -57.27%.

  • When is X4 Pharmaceuticals, Inc.'s Earnings Date?

    X4 Pharmaceuticals, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 1.39% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock